Coronavirus Disease 2019 (COVID-19) Vaccination Coverage, Intentions, Attitudes, and Barriers by Race/Ethnicity, Language of Interview, and Nativity-National Immunization Survey Adult COVID Module, 22 April 2021-29 January 2022.

The National Immunization Survey Adult COVID Module used a random-digit-dialed phone survey during 22 April 2021-29 January 2022 to quantify coronavirus disease 2019 (COVID-19) vaccination, intent, attitudes, and barriers by detailed race/ethnicity, interview language, and nativity. Foreign-born respondents overall and within racial/ethnic categories had higher vaccination coverage (80.9%), higher intent to be vaccinated (4.2%), and lower hesitancy toward COVID-19 vaccination (6.0%) than US-born respondents (72.6%, 2.9%, and 15.8%, respectively). Vaccination coverage was significantly lower for certain subcategories of national origin or heritage (eg, Jamaican [68.6%], Haitian [60.7%], Somali [49.0%] in weighted estimates). Respondents interviewed in Spanish had lower vaccination coverage than interviewees in English but higher intent to be vaccinated and lower reluctance. Collection and analysis of nativity, detailed race/ethnicity and language information allow identification of disparities among racial/ethnic subgroups. Vaccination programs could use such information to implement culturally and linguistically appropriate focused interventions among communities with lower vaccination coverage.

Prevalence and characteristics of children at increased risk for complications from influenza, United States, 2000.

OBJECTIVES: Annual influenza vaccination is recommended for children at high risk of complications from influenza due to underlying medical conditions, but few children are vaccinated. Vaccination also is encouraged for all children aged 6 to 23 months when feasible. This study describes the prevalence and characteristics of at-risk children nationwide. STUDY DESIGN: A descriptive analysis of the 2000 National Health Interview Survey (NHIS) was conducted among children in the United States aged 6 months through 17 years with identified high-risk conditions, and among all children aged 6 to 23 months. RESULTS: Approximately 5.2 to 10.0 million children aged 6 months through 17 years (7.4%-14.2%) had high-risk conditions indicated for influenza vaccination. Asthma accounted for the majority of conditions. An estimated 7.7 million children would be aged 6 to 23 months during influenza season. Most young children and older children at high-risk have access to and frequently utilize healthcare services. CONCLUSIONS: Existing doctor visits are important opportunities for vaccinating children with high-risk conditions, or for those aged 6 to 23 months. Additional efforts are needed to implement and evaluate efficient strategies for annual influenza vaccination of children aged 6 to 23 months and for older children with medical indications.